The Impact of Novel Anti-Diabetic Medications on CV Outcomes: A New Therapeutic Horizon for Diabetic and Non-Diabetic Cardiac Patients

It is estimated that in the past two decades the number of patients diagnosed with diabetes mellites (DM) has doubled. Despite significant progress in the treatment of cardiovascular disease (CVD), including novel anti-platelet agents, effective lipid-lowering medications, and advanced revasculariza...

Descripción completa

Detalles Bibliográficos
Autores principales: Mazin, Israel, Chernomordik, Fernando, Fefer, Paul, Matetzky, Shlomi, Beigel, Roy
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9000034/
https://www.ncbi.nlm.nih.gov/pubmed/35407513
http://dx.doi.org/10.3390/jcm11071904

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9000034/
https://www.ncbi.nlm.nih.gov/pubmed/35407513
http://dx.doi.org/10.3390/jcm11071904

Ejemplares similares